Clinical Trial Update: A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy

View source ↗

Summary

An ongoing Italy-based study evaluating oral venetoclax plus subcutaneous azacitidine in adults with de novo acute myeloid leukemia who are ineligible for inten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VIDAZA (AZACITIDINE)
• Venclyxto (Venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia | Status: ACTIVE_NOT_RECRUITING